Med Mal Infect. 2024; 29(4):237-257.
PMID: 38620207
PMC: 7130595.
DOI: 10.1016/S0399-077X(99)80032-8.
Alvarez-Rocha L, Alos J, Blanquer J, Alvarez-Lerma F, Garau J, Guerrero A
Med Intensiva. 2024; 29(1):21-62.
PMID: 38620135
PMC: 7131443.
DOI: 10.1016/S0210-5691(05)74199-1.
van der Bie S, Haaksma M, Vermin B, van Assema H, van Gorp E, Langerak T
J Clin Med. 2024; 13(2).
PMID: 38256606
PMC: 10816170.
DOI: 10.3390/jcm13020472.
Nohl A, Hamsen U, Jensen K, Sprengel K, Ziegenhain F, Lefering R
Eur J Trauma Emerg Surg. 2020; 48(1):659-665.
PMID: 33221987
DOI: 10.1007/s00068-020-01545-4.
Nair G, Niederman M
Pharmacol Ther. 2020; 217:107663.
PMID: 32805298
PMC: 7428725.
DOI: 10.1016/j.pharmthera.2020.107663.
Femtoliter droplet confinement of Streptococcus pneumoniae: bacterial genetic transformation by cell-cell interaction in droplets.
Lam T, Brennan M, Morrison D, Eddington D
Lab Chip. 2019; 19(4):682-692.
PMID: 30657515
PMC: 6487891.
DOI: 10.1039/c8lc01367e.
Pneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged <5 years prior to the introduction of 10-valent pneumococcal conjugate vaccine - Kenya, 2009-2010.
Kobayashi M, Conklin L, Bigogo G, Jagero G, Hampton L, Fleming-Dutra K
BMC Infect Dis. 2017; 17(1):25.
PMID: 28056828
PMC: 5217209.
DOI: 10.1186/s12879-016-2103-0.
Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.
Kim L, McGee L, Tomczyk S, Beall B
Clin Microbiol Rev. 2016; 29(3):525-52.
PMID: 27076637
PMC: 4861989.
DOI: 10.1128/CMR.00058-15.
Utility of prior screening for methicillin-resistant Staphylococcus aureus in predicting resistance of S. aureus infections.
MacFadden D, Elligsen M, Robicsek A, Ricciuto D, Daneman N
CMAJ. 2013; 185(15):E725-30.
PMID: 24016794
PMC: 3796621.
DOI: 10.1503/cmaj.130364.
Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.
Schechner V, Temkin E, Harbarth S, Carmeli Y, Schwaber M
Clin Microbiol Rev. 2013; 26(2):289-307.
PMID: 23554418
PMC: 3623381.
DOI: 10.1128/CMR.00001-13.
Efficacy and tolerability of moxifloxacin in 2338 patients with acute exacerbation of chronic bronchitis.
Barth J, Landen H
Clin Drug Investig. 2013; 23(1):1-10.
PMID: 23319088
DOI: 10.2165/00044011-200323010-00001.
Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008.
Crowther-Gibson P, Cohen C, Klugman K, de Gouveia L, von Gottberg A
Antimicrob Agents Chemother. 2012; 56(10):5088-95.
PMID: 22802256
PMC: 3457358.
DOI: 10.1128/AAC.06463-11.
Clinical features of spinal infection in individuals older than eighty years.
Nagashima H, Nanjo Y, Tanida A, Dokai T, Teshima R
Int Orthop. 2011; 36(6):1229-34.
PMID: 22190059
PMC: 3353088.
DOI: 10.1007/s00264-011-1440-2.
Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality.
Welte T
Eur J Clin Microbiol Infect Dis. 2011; 31(1):33-47.
PMID: 21533875
DOI: 10.1007/s10096-011-1272-4.
Adult community-acquired bacterial meningitis requiring ICU admission: epidemiological data, prognosis factors and adherence to IDSA guidelines.
Georges H, Chiche A, Alfandari S, Devos P, Boussekey N, Leroy O
Eur J Clin Microbiol Infect Dis. 2009; 28(11):1317-25.
PMID: 19727871
DOI: 10.1007/s10096-009-0782-9.
Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia.
Vila-Corcoles A, Bejarano-Romero F, Salsench E, Ochoa-Gondar O, de Diego C, Gomez-Bertomeu F
BMC Infect Dis. 2009; 9:36.
PMID: 19320989
PMC: 2667188.
DOI: 10.1186/1471-2334-9-36.
Improving outcomes of elderly patients with community-acquired pneumonia.
Gutierrez F, Masia M
Drugs Aging. 2008; 25(7):585-610.
PMID: 18582147
DOI: 10.2165/00002512-200825070-00005.
Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin.
Oncu S
Ther Clin Risk Manag. 2008; 3(3):441-8.
PMID: 18488076
PMC: 2386358.
Once-daily moxifloxacin therapy for community-acquired pneumonia in general practice : evidence from a post-marketing surveillance study of 1467 patients.
Koch H, Landen H, Stauch K
Clin Drug Investig. 2007; 24(8):441-8.
PMID: 17523704
DOI: 10.2165/00044011-200424080-00002.
Efficacy and tolerability of moxifloxacin in patients with sinusitis treated in general practice : results of a post-marketing surveillance study.
Elies W, Landen H, Stauch K
Clin Drug Investig. 2007; 24(8):431-9.
PMID: 17523703
DOI: 10.2165/00044011-200424080-00001.